A new approach to late onset myasthenia gravis.
نویسندگان
چکیده
We have demonstrated that thymectomy alone can improve many patients with myasthenia gravis, including those with the late onset form of the disorder. A key advantage to this approach is that it avoids the necessity of concurrent medication. While a drug-free approach has advantages for any patient, it is particularly well suited for those over the age of 55. Based on the results of our study, we believe that early, total thymectomy is the preferred treatment for patients with myasthenia gravis.
منابع مشابه
Late-onset myasthenia gravis: a changing scene.
The prevalence of myasthenia gravis (MG) among middle-aged and older patients has increased. Patients with early-onset MG live longer than before, but there is also an increase in late-onset MG (onset of the disease after the age of 50 years in patients with no clinical or paraclinical evidence of a thymoma). Epidemiological data support using the age of 50 years to separate early- and late-ons...
متن کاملComparison of Two Different Induction Doses of Atracurium in Myasthenia Gravis in Patients Undergoing Thymectomy
Introduction:yasthenia gravis is an autoimmune disorder resulting from a decreased number of active acetylcholine receptors at the neuromuscular junction. Thymectomy is one of its current treatments. Due to sensitivity of myasthenic patients to non-depolarizing muscle relaxants and also the interaction of this medication with anti-cholinestrase drugs, determining the dosage of non-depolarizing ...
متن کاملAn Unusual Presentation of Myasthenia Gravis
Myasthenia gravis (MG) is a rare, autoimmune neuromuscular junction disorder. Prevalence rates approach 1/5,000. MG presents with painless, fluctuating, fatigable weakness involving specific muscle groups. It occurs more common in younger individuals. Late-onset MG is more frequent in elderly men and is often misdiagnosed. We present a case of an 80 year old male presented with ocular weakness ...
متن کاملMyasthenia gravis: subgroup classification and therapeutic strategies.
Myasthenia gravis is an autoimmune disease that is characterised by muscle weakness and fatigue, is B-cell mediated, and is associated with antibodies directed against the acetylcholine receptor, muscle-specific kinase (MUSK), lipoprotein-related protein 4 (LRP4), or agrin in the postsynaptic membrane at the neuromuscular junction. Patients with myasthenia gravis should be classified into subgr...
متن کاملAnti-MuSK-Positive Myasthenia Gravis in a Patient with Parkinsonism and Cognitive Impairment
Muscle-specific tyrosine kinase- (MuSK-) antibodies-positive Myasthenia Gravis accounts for about one third of Seronegative Myasthenia Gravis and is clinically characterized by early onset of prominent bulbar, neck, shoulder girdle, and respiratory weakness. The response to medical therapy is generally poor. Here we report a case of late-onset MuSK-antibodies-positive Myasthenia Gravis presenti...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Geriatrics
دوره 39 1 شماره
صفحات -
تاریخ انتشار 1984